Jayaprakash et al. (2018) reported that hypoxic zones were prevalent in preclinical prostate cancer and resisted T-cell infiltration, even in the context of CTLA-4 and PD-1 blockade [243]. The gene discussed is PDCD1; the disease is prostate carcinoma.